Publication Author: Sullivan_Sean

• Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction.

  Hallstrand TS, Curtis JR, Koepsell TD, Martin DP, Schoene RB, Sullivan SD, Yorioka GN, Aitken ML. Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr. 2002 Sep;141(3):343-8.

  rakerr2

  September 1, 2002

• Lipid-lowering drug use and cardiovascular events after myocardial infarction.

  Klungel OH, Heckbert SR, de Boer A, Leufkens HG, Sullivan SD, Fishman PA, Veenstra DL, Psaty BM. Lipid-lowering drug use and cardiovascular events after myocardial infarction. Ann Pharmacother. 2002 May;36(5):751-7.

  rakerr2

  May 1, 2002

• Collaborative care model to improve outcomes in major depression.

  Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL, Katon WJ, Walker EA, Stevens NG. Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002 Apr;36(4):585-91.

  rakerr2

  April 1, 2002

• The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain.

  Hollingworth W, Deyo RA, Sullivan SD, Emerson SS, Gray DT, Jarvik JG. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Econ. 2002 Jan;11(1):71-85.

  rakerr2

  January 1, 2002

• Economic issues and antibiotic resistance in the community.

  Reed SD, Laxminarayan R, Black DJ, Sullivan SD. Economic issues and antibiotic resistance in the community. Ann Pharmacother. 2002 Jan;36(1):148-54. Review.

  rakerr2

  January 1, 2002

• A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment.

  Veenstra DL, Ramsey SD, Sullivan SD. A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment. Pharmacoeconomics. 2002;20 Suppl 1:21-30.

  rakerr2

  January 1, 2002

• Health state preference assessment in diabetic peripheral neuropathy.

  Sullivan SD, Lew DP, Devine EB, Hakim Z, Reiber GE, Veenstra DL. Health state preference assessment in diabetic peripheral neuropathy. Pharmacoeconomics. 2002;20(15):1079-89.

  rakerr2

  January 1, 2002

• Modeling the cost and outcomes of pharmacist-prescribed emergency contraception.

  Marciante KD, Gardner JS, Veenstra DL, Sullivan SD. Modeling the cost and outcomes of pharmacist-prescribed emergency contraception. Am J Public Health. 2001 Sep;91(9):1443-5.

  rakerr2

  September 1, 2001

• Management strategies for ribavirin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications.

  Devine EB, Kowdley KV, Veenstra DL, Sullivan SD. Management strategies for ribavirin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implications. Value Health. 2001 Sep-Oct;4(5):376-84. Review.

  rakerr2

  September 1, 2001

• Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial.

  Sullivan SD, Liljas B, Buxton M, Lamm CJ, O’Byrne P, Tan WC, Weiss KB; START Steering Committee. Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial. Control Clin Tri

  rakerr2

  August 1, 2001